Erin PowellAssociate Professor (Medical Oncology) and Residency Program Director (Oncology) BA Memorial, BSc. Memorial, MD Memorial FRCPC
(709)777-7802 (Clinical)/(709) 777-8751 (Academic)
Dr. H. Bliss Murphy Cancer Clinic 300 Prince Phillip Dr. St. John's, NL A1B 3V6
Dr. Erin Powell is a Medical Oncologist at the Dr. H. Bliss Murphy Cancer Center with a focus on Breast Cancer. She graduated from Memorial University Faculty of Medicine in 2004 and completed her Internal Medicine Residency at Memorial in 2007. She went on to Medical Oncology training at the University of Ottawa and returned to St. John’s as a Medical Oncologist in 2009. She is currently the Program Director for the Medical Oncology Training Program which began in 2015.
Dr. Powell is also the Co-Chair for the Canadian Association of Medical Oncologist’s Annual Scientific Meeting in 2020 and 2021.
M. Rodrigue, J. Fawcett, J. Rash, R. Lester, E. Powell, C. MacMillan, S. Garland. Factors associated with cognitive impairment during the first year of treatment for non-metastatic breast cancer. Cancer
Virtual SLEEP 2020, entitled 1045 Impact Of Pre-treatment Sleep And Menopausal Status On Sleep Quality In The 12 Months Following A Breast Cancer Diagnosis
Squires, L., Mahon, K., Rash, J., Powell, E., Seal, M, & Garland, S. N. (2020). Impact of Pre-treatment Sleep And Menopausal Status On Sleep Quality In The 12 Months Following A Breast Cancer Diagnosis. Poster presented at the meeting of the Associated Professional Sleep Societies on June 15-17, 2020 in Philadelphia, PA
Feng J, Harnett B, Squirell E, Powell E and Jones D, Grassroots Initiatives for Resident Wellness at Memorial University of Newfoundland, Canadian Conference on Physician Health, Poster presentation, October 2019
Hyde AJ, Nassabein R....Powell E, Ramjeesingh R, Saliba W, Singh R, Snow S, Stuckless T, Tadros S, Tehfe M, Thana M, Thirwell M, Vickers M, Virik K, Welch S and Asmis T, Eastern Canadian Gastrointestinal Cancer Consensus Conference 2018, Curr Oncol. 2019 October; 26(5):e665-e681
Mahon, K, Garland, S.N., Rash, J., Wall, K., Lester, R., Powell, E., & Laing, K. Prevalence and factors associated with pre-treatment insomnia symptoms in women with early stage breast cancer, Sleep (final publication date pending)
Elizabeth Dicks PhD, Rebecca Roome, Joanne Chafe RN,MN, Erin Powell MD, Farah McCrate PhD, Charlene Simmonds PhD, Holly Etchegary PhD. Factors influencing surgical treatment decisions for breast cancer: A qualitative exploration of surgeon and patient perspective, Current Oncology, Volume 26, N 2 (2019)
F. McCrate, E. Dicks, E. Powell, J. Chafe, C. Simmonds, H. Etchegary. Surgical treatment choices for breast cancer in Newfoundland and Labrador: a Retrospective Cohort Study, Can J Surg, October 1 2018
J. Lebert, R. Lester, E. Powell, M. Seal and J. McCarthy. Advances in the Systemic Treatment of Triple Negative Breast Cancer, Curr Oncol. 2018 Jun 25(S1):S142-S150
S. Dudani, M. Maginean, J, Gotfrit, P. Tang, J. Monzon, K. Dennis, H. Kennecke, E. Powell, S. Babak, W. Cheung, M. Vickers. The impact of chronic kidney disease in locally advanced rectal cancer patients treated with neoadjuvant chemoradiation. Poster presentation at GI ASCO, January 2018
Sam Babak, Erin Powell, Dawn Armstrong. Clinical outcomes of elderly patients with locally advanced rectal cancer who received neoadjuvant chemoradiation: A retrospective cohort study of a single institution. Poster presentation at the Canadian Association of Medical Oncologists Annual Scientific Symposium, April 2017
Gregory Doyle, Erin Powell, Elaine Warren, Nancy Wadden, Donald Cook, Christopher Cox, Elizabeth Bannister, Suzanne Condon, Lori Manuel. Using the LEAN Management Process to Reduce the Wait-Time from Abnormal Mammogram to the Diagnosis and Treatment of Breast Cancer, Innovative Approaches to Optimal Cancer Care in Canada conference, April 7-8, 2017, Toronto, Ontario.
Loree JM, Kennecke HF, Lee-Ying RM, Goodwin RA, Powell ED, Tang PA, Price Hiller JA, Vickers MM and Cheug WY. Impact of post-operative adjuvant chemotherapy following long-course chemoradiotherapy in stage II rectal cancer, Am J Clin Oncol. 2016
Dominick Bossé, M.D., M.Sc.; Jamison Mercer; Soundouss Raissouni; Kristopher Dennis; Rachel Goodwin; Di Jiang; Erin Powell; Aalok Kumar; Richard Lee-Ying; Julie Price-Hiller; Daniel Y. C. Heng; Patricia A Tang; Anthony MacLean; Winson Y Cheung; Michael M Vickers. PROSPECT eligibility and clinical outcomes: Results from the pan-Canadian rectal cancer consortium (CCRC MS# CCRC-D-15-00201R1), Clinical Colorectal Cancer
Clincal Outcomes Of Elderly Patients Receiving Neoadjuvant Chemoradiation for Locally Advanced Rectal Cancer. D. M. Jiang, S. Raissouni,J. Mercer,A. Kumar, R. Goodwin, D. Y. Heng, P. A. Tang, C. Doll, A. MacLean,E. Powell, J. Price-Hiller, J. Monzon, W. Y. Cheung and M. M. Vickers,* Ann Oncol (2015) 26 (10): 2102-2106.
Armstrong, D., Raissouni, S., Hiller, J. P., Mercer, J., Powell, E., MacLean, A., & Zhou, K. (2015). Predictors of Pathologic Complete Response After Neoadjuvant Treatment for Rectal Cancer: A Multicenter Study. Clinical colorectal cancer, 14(4), 291-295.
D. Bossé, J. Mercer, S. Raissouni, K. Dennis, R. Goodwin, M. Jiang, E. Powell, A. Kumar, R. Lee-Ying, J. Price Hiller, D. Y. Heng, P. A. Tang, A. MacLean, W. Y. Cheung, M. M. Vickers. PROSPECT eligibility and clinical outcomes: Results from the pan-Canadian rectal cancer consortium, Poster Presentation at ASCO 2015